BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,835.00
-120.00 (-2.42%)
At close: Jan 19, 2026
-16.06%
Market Cap22.47B
Revenue (ttm)21.92B -16.2%
Net Income-5.63B
EPS-1,157.24
Shares Out4.86M
PE Ration/a
Forward PEn/a
Dividend400.00 (8.27%)
Ex-Dividend DateDec 29, 2025
Volume6,463
Average Volume10,907
Open4,980.00
Previous Close4,955.00
Day's Range4,820.00 - 4,980.00
52-Week Range4,535.00 - 7,620.00
Beta0.69
RSI48.18
Earnings Daten/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

Financial Performance

Financial Statements